Business
The Power Play by The Market Herald Releases New Interviews with Spey Resources, Melkior Resources and BioVaxys Technology Discussing Their Latest News
VANCOUVER, BC / ACCESSWIRE / March 16, 2023 / The Power Play by The Market Herald has announced ...
About this update from Melkior Resources Inc.
[{"type":"text","content":"The Power Play by The Market Herald Releases New Interviews with Spey Resources, Melkior Resources and BioVaxys Technology Discussing Their Latest NewsVANCOUVER, BC / ACCESSWIRE / March 16, 2023 / The Power Play by The Market Herald has announced the release of new interviews with Spey Resources, Melkior Resources and BioVaxys Technology discussing their latest news.The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.Spey (CSE:SPEY) evaluating potential resource estimate study at Incahuasi Salar Spey (SPEY) is progressing with its drilling and exploration plan at its Incahuasi Salar property in Argentina. It intends to build a potential resource estimate study for the Candela II area, with bid proposals expected soon. It secured a contractor for a magnetotelluric survey at Candela II in April 2023 motivated by drilling yields as high as 173 ppm Li. CEO Phillip Thomas spoke with Simon Druker about the news.For the full interview with Phillip Thomas and to learn about Spey, click here.Melkior (TSXV:MKR) intersects high-potential copper in Timmins Melkior (MKR) has announced encouraging results from its maiden program at the Genex Project in Timmins, Ontario. Highlights include 0.96 per cent Cu and 0.22 g/t Au over 27.0 m, including 2.29 per cent Cu and 0.32 g/t Au over 7.78 m (GEN-22-01). The results demonstrate wide development possibility with significant near-term resource potential. CEO Jonathon Deluce spoke with Coreena Robertson about the discovery.For the full interview with Jonathon Deluce and to learn about Melkior, click here.BioVaxys (CSE:BIOV) acquires TAETSoftware, completes financing BioVaxys (BIOV) has acquired TAETSoftware, a Vancouver-based clinical studies management company. TAETSoftware is developing a software application for clinical study subjects to record and submit Adverse Drug Events reports to study sponsors in real time. Consideration includes 24,500,000 common shares, with an additional 2,500,000 common shares payable upon the successful testing of the application's beta version. CEO James Passin joined Coreena Robertson to discuss the news.For the full interview with James Passin and to learn about BioVaxys, click here.Interviews for The Power P...